GB0118009D0 - Novel preparation - Google Patents

Novel preparation

Info

Publication number
GB0118009D0
GB0118009D0 GBGB0118009.0A GB0118009A GB0118009D0 GB 0118009 D0 GB0118009 D0 GB 0118009D0 GB 0118009 A GB0118009 A GB 0118009A GB 0118009 D0 GB0118009 D0 GB 0118009D0
Authority
GB
United Kingdom
Prior art keywords
novel preparation
novel
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0118009.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
REGMA BIOTECHNOLOGIES Ltd
Original Assignee
REGMA BIOTECHNOLOGIES Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by REGMA BIOTECHNOLOGIES Ltd filed Critical REGMA BIOTECHNOLOGIES Ltd
Priority to GBGB0118009.0A priority Critical patent/GB0118009D0/en
Publication of GB0118009D0 publication Critical patent/GB0118009D0/en
Priority to PCT/GB2002/003384 priority patent/WO2003010316A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1278—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Bacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10311—Siphoviridae
    • C12N2795/10332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
GBGB0118009.0A 2001-07-24 2001-07-24 Novel preparation Ceased GB0118009D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0118009.0A GB0118009D0 (en) 2001-07-24 2001-07-24 Novel preparation
PCT/GB2002/003384 WO2003010316A1 (en) 2001-07-24 2002-07-24 Bacteriophage-mediated lysis anthrax bacteria

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0118009.0A GB0118009D0 (en) 2001-07-24 2001-07-24 Novel preparation

Publications (1)

Publication Number Publication Date
GB0118009D0 true GB0118009D0 (en) 2001-09-19

Family

ID=9919082

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0118009.0A Ceased GB0118009D0 (en) 2001-07-24 2001-07-24 Novel preparation

Country Status (2)

Country Link
GB (1) GB0118009D0 (en)
WO (1) WO2003010316A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1501925A4 (en) * 2002-05-17 2006-10-25 New Horizons Diagnostics Corp Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis
US7601351B1 (en) 2002-06-26 2009-10-13 Human Genome Sciences, Inc. Antibodies against protective antigen
CN101003569B (en) * 2007-01-19 2010-06-23 中国人民解放军军事医学科学院生物工程研究所 Antigen epitope and mutant of lyase in gamma bacteriophage of anthrax bacillus, and application

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5677274A (en) * 1993-02-12 1997-10-14 The Government Of The United States As Represented By The Secretary Of The Department Of Health And Human Services Anthrax toxin fusion proteins and related methods
WO1998005344A1 (en) * 1996-08-05 1998-02-12 Brigham And Women's Hospital, Inc. Bacteriophage-mediated gene therapy
WO2000002523A2 (en) * 1998-07-10 2000-01-20 U.S. Medical Research Institute Of Infectious Diseases Department Of The Army Vaccine against staphylococcus intoxication
CA2366712A1 (en) * 1999-02-25 2000-08-31 Vincent Fischetti A means for the prophylactic and therapeutic treatment of streptococcal infections
GB9908195D0 (en) * 1999-04-09 1999-06-02 Microbiological Res Authority Treatment of intracellular infection
AU2001229342A1 (en) * 2000-01-11 2001-07-24 Intralytix, Inc. Method for produce sanitation using bacteriophages

Also Published As

Publication number Publication date
WO2003010316A1 (en) 2003-02-06

Similar Documents

Publication Publication Date Title
HU0401339D0 (en) Novel 4-anilinoquinoline-3-carboxamides
PL367308A1 (en) Novel use
GB0100762D0 (en) Novel use
GB0115181D0 (en) Novel use
AU2002360430A8 (en) 14-methyl-epothilones
EP1384783A4 (en) Novel maxizyme
HU0400176V0 (en) Improved gasketseal
GB0115385D0 (en) Novel preparation
EG23036A (en) Novel pyrrolecarboxamides
GB0118009D0 (en) Novel preparation
AU2002313943A8 (en) Electromobile
PL367864A1 (en) Novel combination
PL364076A1 (en) Novel pyridylmethylaminopyrimidines
GB0103763D0 (en) Pak-Gep Construct
AU2001100134A4 (en) Enviro-trap
GB0119169D0 (en) Novel pyridyl-piperazines
CA93125S (en) Tilt-latch
AU2288P (en) Prime322 xTriticosecale
CA91502S (en) Bedboard
CA92665S (en) Bedboard
CA92978S (en) Photo-changer
CA93075S (en) Travelbag
AU2479P (en) Crackerjack xTriticosecale
GB0118919D0 (en) Novel use
GB0100852D0 (en) Novel use

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application
AT Applications terminated before publication under section 16(1)